Patents by Inventor Yong Ji

Yong Ji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10526373
    Abstract: The present invention provides a peptide which shows a melanin generation-promoting activity. The peptide of the present invention increases the activity and expression of tyrosinase and increases the expression of factors related to melanin generation, thereby showing an excellent effect in melanin generation. The peptide of the present invention can be used for preventing, alleviating, and treating hypomelanosis. The above-mentioned superior activity and stability of the peptide of the present invention allows the peptide to be very favorably applied to medicines, quasi drugs, and cosmetics.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: January 7, 2020
    Assignee: Caregen Co., Ltd.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung-Ji Lee, Jan Di Kim
  • Publication number: 20190384729
    Abstract: A method, computer program product, and system includes a processing circuit(s) allocating a page of system memory address space to a device. The allocating includes the processing circuits(s) obtaining base address registers of the device in a bus and determining a portion of the page of the system memory address space to allocate to the base address registers. The processing circuits(s) sorts the base address registers, in a descending order, according to their alignments and adds sizes of the sorted base address registers to determine the portion of the page. The processing circuit(s) determines a remainder of the page: a difference between a size of the page and the portion of the page. The processing circuit(s) requests a virtual resource of a size equal to the remainder and allocates the page to the sorted base address registers and to the virtual resource.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 19, 2019
    Inventors: Bo Qun BQ Feng, Zhong Li, Xian Dong Meng, Yong Ji JX Xie
  • Patent number: 10508140
    Abstract: The present invention provides: a peptide which shows a hair growth-promoting activity and/or a melanin generation-promoting activity; a composition for preventing and/or alleviating hair loss, comprising the peptide as an effective ingredient; a composition for promoting hair growth, comprising the peptide as an effective ingredient; a use of the peptide for preventing and/or alleviating hair loss; a use of the peptide for promoting hair growth; a pharmaceutical composition for preventing and/or treating hypomelanosis, comprising the peptide as an effective ingredient; a cosmetic composition for preventing and/or treating hypomelanosis, comprising the peptide as an effective ingredient; and a use of the peptide for preventing and/or treating hypomelanosis.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: December 17, 2019
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung-Ji Lee
  • Publication number: 20190374599
    Abstract: The present invention relates to an antibacterial, anti-inflammatory, or antioxidant composition and, more specifically, to a compound having a structure in which salicylic acid is linked to a peptide via a covalent linkage, and to an antibacterial, anti-inflammatory, or antioxidant pharmaceutical or cosmetic composition containing the compound. The compound having a structure in which salicylic acid is linked to a peptide via a covalent linkage, of the present invention, has excellent physiological activity, such as antibacterial, anti-inflammatory, or antioxidant activity, as well as excellent characteristics, such as solubility in water, and thus the compound can be favorably used in various fields of food, drug, or cosmetics.
    Type: Application
    Filed: February 16, 2017
    Publication date: December 12, 2019
    Inventors: Yong Ji CHUNG, Eun Mi KIM
  • Patent number: 10487113
    Abstract: A peptide having activity to improve skin condition is described. The peptide exhibits a very excellent effect in improving skin condition by inhibiting MMP2 activity. A composition containing the peptide exhibits excellent biological activities, such as inhibiting collagen decomposition and melanosome migration, and thus can be used in wrinkle reduction, skin regeneration, skin elasticity improvement, anti-skin aging, wound regeneration, acne reduction, skin regeneration or skin whitening. The composition containing the peptide can be used as a pharmaceutical composition for preventing or treating MMP activity-related diseases and inflammation diseases.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: November 26, 2019
    Assignee: Caregen Co., Ltd.
    Inventors: Yong Ji Chung, Eun Mi Kim
  • Patent number: 10475728
    Abstract: An apparatus for bonding a flexible part including inclined leads is provided, more particularly, an apparatus for bonding a flexible part including inclined leads, which aligns parts to bond the parts is provided. According to the apparatus for bonding a flexible part including inclined leads, an electronic part may be easily bonded to a part having an inclined surface.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: November 12, 2019
    Assignee: PROTEC CO., LTD.
    Inventors: Moo Sup Shim, Seong Yong Ji, Hyoung Yeon Ju, Chiho Cho
  • Patent number: 10472418
    Abstract: A use of prevention or treatment of lung cancer including an antibody specifically recognizing CD66c in lung cancer or its antigen-binding fragment and a chemotherapeutic agent is provided.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: November 12, 2019
    Assignee: Dinona
    Inventors: Kwon Pyo Hong, Mi Hyang Shin, Sangsoon Yoon, Gil Yong Ji, Yoo Ri Moon
  • Publication number: 20190328642
    Abstract: The present invention provides a peptide having skin-whitening activity. The peptide of the present invention exhibits an excellent skin whitening effect by inhibiting melanogenesis, inhibiting the activity of tyrosinase, inhibiting the expression of melanosis-involved factors, and inhibiting melanosome transfer. The peptide of the present invention has excellent skin permeability due to the small size thereof. Excellent activity and stability of the foregoing peptide of the present invention can be very favorably applied to cosmetics.
    Type: Application
    Filed: April 27, 2017
    Publication date: October 31, 2019
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung-Ji LEE, Jan Di KIM
  • Publication number: 20190270772
    Abstract: A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of PPAR?, ACC, and aP2, which are adipogenic markers, increase the expression of pHSL, AMPK-?1, CGI-58, and ATGL, which are lipolytic factors, and reduce the size of fat cells and blood cholesterol values. The peptide and the peptide complex of the present invention, which have excellent activity and safety, can be advantageously applied to drugs and quasi-drugs.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 5, 2019
    Applicant: CAREGEN CO., LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM
  • Publication number: 20190270773
    Abstract: A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of PPAR?, ACC, and aP2, which are adipogenic markers, increase the expression of pHSL, AMPK-?1, CGI-58, and ATGL, which are lipolytic factors, and reduce the size of fat cells and blood cholesterol values. The peptide and the peptide complex of the present invention, which have excellent activity and safety, can be advantageously applied to drugs and quasi-drugs.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 5, 2019
    Applicant: CAREGEN CO., LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM
  • Publication number: 20190270774
    Abstract: A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of PPAR?, ACC, and aP2, which are adipogenic markers, increase the expression of pHSL, AMPK-?1, CGI-58, and ATGL, which are lipolytic factors, and reduce the size of fat cells and blood cholesterol values. The peptide and the peptide complex of the present invention, which have excellent activity and safety, can be advantageously applied to drugs and quasi-drugs.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 5, 2019
    Applicant: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim
  • Publication number: 20190263905
    Abstract: The present invention relates to an anti-CD66c antibody and its use for treating cancer, and more particularly, it is possible to induce T-cell activation or humoral immune response using an antibody specifically recognizing CD66c. A nucleic acid molecule encoding the antibody or antigen-binding fragment thereof, a vector comprising the nucleic acid molecule, a host cell and the antibody or antigen-binding fragment thereof is used for alleviation, prevention, treatment or diagnosis of CD66c-related disease.
    Type: Application
    Filed: November 14, 2017
    Publication date: August 29, 2019
    Inventors: Sangsoon YOON, Kwon Pyo HONG, Soseul KIM, Gil Yong JI, Young Hoon LIM
  • Patent number: 10384286
    Abstract: A method of bonding a flexible part including inclined leads is provided, and more particularly, a method of bonding a flexible part including inclined leads, in which parts are aligned to bond the parts is provided. According to the method of bonding the flexible part including inclined leads, an electronic part may be easily bonded to a part having an inclined surface.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: August 20, 2019
    Assignee: PROTEC CO., LTD.
    Inventors: Moo Sup Shim, Seong Yong Ji, Hyoung Yeon Ju, Chiho Cho
  • Patent number: 10351598
    Abstract: The present invention provides peptides with an anti-obesity and/or anti-diabetic activity consisting of an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2, and optionally modified at their C- or N-terminal ends.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: July 16, 2019
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim
  • Patent number: 10351597
    Abstract: A peptide and a peptide complex of the present invention exhibit an anti-obesity effect by inhibiting fat accumulation and decomposing already accumulated fat, and exhibit an excellent effect with respect to diabetes by effectively reducing blood sugar. The peptide and the peptide complex of the present invention decrease the expression of PPAR?, ACC, and aP2, which are adipogenic markers, increase the expression of pHSL, AMPK-?1, CGI-58, and ATGL, which are lipolytic factors, and reduce the size of fat cells and blood cholesterol values. The peptide and the peptide complex of the present invention, which have excellent activity and safety, can be advantageously applied to drugs and quasi-drugs.
    Type: Grant
    Filed: May 12, 2015
    Date of Patent: July 16, 2019
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim
  • Patent number: 10344061
    Abstract: The present invention relates to peptides exhibiting hair growth promoting activity and/or melanin production promoting activity, a composition for ameliorating hair loss comprising one or both of the peptides as an active ingredient, a composition for promoting hair growth and/or hair restoration comprising one or both of the peptides as an active ingredient, a use of one or both of the peptides for ameliorating hair loss, a use of one or both of the peptides for promoting hair growth and/or hair restoration, a pharmaceutical composition for the treatment of melanin hypopigmentation comprising one or both of the peptides as an active ingredient, a cosmetic composition for the treatment of melanin hypopigmentation comprising one or both of the peptides as an active ingredient, and a use of one or both of the peptides for the amelioration and/or treatment of melanin hypopigmentation.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: July 9, 2019
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung Ji Lee
  • Publication number: 20190192677
    Abstract: The present invention relates to a composition for preventing hair loss and, more specifically, to a compound having a structure in which Minoxidil and a peptide are chemically connected, and to a pharmaceutical composition or cosmetic composition for preventing hair loss or promoting hair growth comprising the compound. The compound having a structure in which Minoxidil and a peptide are chemically connected according to the present invention has not only excellent physiological activity such as hair loss reduction, hair growth promotion or cell growth promotion, but also excellent stability in water, and can therefore be useful as a composition for preventing hair loss and promoting hair growth.
    Type: Application
    Filed: August 4, 2017
    Publication date: June 27, 2019
    Applicant: CAREGEN CO., LTD.
    Inventors: Yong Ji CHUNG, Eun Mi KIM
  • Publication number: 20190153116
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: January 31, 2019
    Publication date: May 23, 2019
    Inventors: Yoo Ri MOON, Gil Yong Ji
  • Publication number: 20190119321
    Abstract: The present invention provides a peptide which shows a melanin generation-promoting activity. The peptide of the present invention increases the activity and expression of tyrosinase and increases the expression of factors related to melanin generation, thereby showing an excellent effect in melanin generation. The peptide of the present invention can be used for preventing, alleviating, and treating hypomelanosis. The above-mentioned superior activity and stability of the peptide of the present invention allows the peptide to be very favorably applied to medicines, quasi drugs, and cosmetics.
    Type: Application
    Filed: February 13, 2017
    Publication date: April 25, 2019
    Inventors: Yong Ji CHUNG, Eun Mi KIM, Eung-Ji LEE, Jan Di KIM
  • Publication number: 20190100556
    Abstract: The present invention provides a peptide with an anti-obesity and/or anti-diabetic activity consisting of an amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2. The peptide of the present invention exhibits an excellent anti-obesity effect by inhibiting fat accumulation, reducing the sizes of adipocytes, and breaking down accumulated fat through an increase in the expression of lipolytic factors pHSL and AMPK-?1, and CGI-58, and furthermore, an excellent effect on diabetes by increasing an expression of adiponectin and AMPK which effectively reduce blood glucose and improves insulin resistance, increasing the expression of glucose transporter GLUT4, and increasing an expression of IRS-1, an insulin receptor signal transduction protein. The peptide of the present invention can be effectively used for the prevention or treatment of obesity and/or diabetes.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 4, 2019
    Inventors: Yong Ji CHUNG, Eun Mi KIM